PKD2 anticorps (AA 680-968)

N° du produit ABIN7163836

Cet anticorps anti-PKD2 est un anticorps Lapin Polyclonal détectant PKD2 dans ELISA, IHC et IF. Adapté pour Humain.

Aperçu rapide pour PKD2 anticorps (AA 680-968) (ABIN7163836)

Antigène: PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PKD2 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Détail du produit anti-PKD2 anticorps

Épitope: AA 680-968

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Polycystin-2 protein (680-968AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur PKD2

Antigène: PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))

Autre désignation: PKD2

Sujet:

Background: Functions as a cation channel involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (PubMed:18695040). Functions as outward-rectifying K(+) channel, but is also permeable to Ca(2+), and to a much lesser degree also to Na(+) (PubMed:11854751, PubMed:15692563, PubMed:27071085, PubMed:27991905). May contribute to the release of Ca(2+) stores from the endoplasmic reticulum (PubMed:11854751, PubMed:20881056). Together with TRPV4, forms mechano- and thermosensitive channels in cilium (PubMed:18695040). PKD1 and PKD2 may function through a common signaling pathway that is necessary to maintain the normal, differentiated state of renal tubule cells. Acts as a regulator of cilium length, together with PKD1. The dynamic control of cilium length is essential in the regulation of mechanotransductive signaling. The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases flow-induced signaling. Also involved in left-right axis specification via its role in sensing nodal flow, forms a complex with PKD1L1 in cilia to facilitate flow detection in left-right patterning. Detection of asymmetric nodal flow gives rise to a Ca(2+) signal that is required for normal, asymmetric expression of genes involved in the specification of body left-right laterality (By similarity).

Aliases: APKD2 antibody, Autosomal dominant polycystic kidney disease type II antibody, Autosomal dominant polycystic kidney disease type II protein antibody, MGC138466 antibody, MGC138468 antibody, PC 2 antibody, PC2 antibody, PKD 2 antibody, PKD2 antibody, PKD2_HUMAN antibody, PKD4 antibody, Polycystic kidney disease 2 (autosomal dominant) antibody, Polycystic kidney disease 2 antibody, Polycystic kidney disease 2 protein antibody, Polycystin 2 antibody, Polycystin 2 transient receptor potential cation channel antibody, Polycystin-2 antibody, Polycystin2 antibody, Polycystwin antibody, R48321 antibody, Transient receptor potential cation channel subfamily P member 2 antibody, TRPP2 antibody

UniProt: Q13563

Pathways: cAMP Metabolic Process, Maintenance of Protein Location, Negative Regulation of Transporter Activity